Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14,648 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M. Nakamura M, et al. J Hepatol. 2007 Jan;46(1):77-88. doi: 10.1016/j.jhep.2006.07.032. Epub 2006 Sep 25. J Hepatol. 2007. PMID: 17045692
Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M. Kondo M, et al. Clin Cancer Res. 2005 Feb 1;11(3):1277-86. Clin Cancer Res. 2005. PMID: 15709199
Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.
Damdinsuren B, Nagano H, Sakon M, Kondo M, Yamamoto T, Umeshita K, Dono K, Nakamori S, Monden M. Damdinsuren B, et al. Ann Surg Oncol. 2003 Dec;10(10):1184-90. doi: 10.1245/aso.2003.03.010. Ann Surg Oncol. 2003. PMID: 14654475
Methylcobalamin decreases mRNA levels of androgen-induced growth factor in androgen-dependent Shionogi carcinoma 115 cells.
Nishizawa Y, Yamamoto T, Tanigaki Y, Kasugai T, Mano M, Ishiguro S, Fushiki S, Poirier LA, Nishizawa Y. Nishizawa Y, et al. Nutr Cancer. 1999;35(2):195-201. doi: 10.1207/S15327914NC352_15. Nutr Cancer. 1999. PMID: 10693175
Transforming growth factor-alpha promotes tumor markers secretion from human ovarian cancers in vitro.
Kurachi H, Adachi H, Morishige K, Adachi K, Takeda T, Homma H, Yamamoto T, Miyake A. Kurachi H, et al. Cancer. 1996 Sep 1;78(5):1049-54. doi: 10.1002/(SICI)1097-0142(19960901)78:5<1049::AID-CNCR15>3.0.CO;2-2. Cancer. 1996. PMID: 8780543
Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model.
Yamamoto T, Arakawa F, Nakamura K, Senba T, Tomita Y, Ikeda S, Kuroki M. Yamamoto T, et al. Cancer Immunol Immunother. 1999 Jul;48(4):165-71. doi: 10.1007/s002620050561. Cancer Immunol Immunother. 1999. PMID: 10431685
Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA).
Mukai M, Imamura F, Ayaki M, Shinkai K, Iwasaki T, Murakami-Murofushi K, Murofushi H, Kobayashi S, Yamamoto T, Nakamura H, Akedo H. Mukai M, et al. Int J Cancer. 1999 Jun 11;81(6):918-22. doi: 10.1002/(sici)1097-0215(19990611)81:6<918::aid-ijc13>3.0.co;2-e. Int J Cancer. 1999. PMID: 10362139
14,648 results
Jump to page
Feedback